Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,791,160
-$1,266,482 QoQ
Shares Held
6,397
-44.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#383
of 1,040 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Northwest & Ethical Investments L.P. holds $55,062,067 across 9 Diagnostics & Research names. LH ranks #5 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
269,114 | $35,746,412 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
23,999 | $12,032,138 | |
| 3 | WAT |
Waters Corp /De/
|
4,862 | $1,823,444 | |
| 4 | DGX |
Quest Diagnostics Inc
|
8,571 | $1,816,623 | |
| 5 | LH |
Labcorp Holdings Inc.
This page
|
6,397 | $1,791,160 | |
| 6 | ILMN |
Illumina, Inc.
|
5,000 | $879,150 | |
| 7 | GH |
Guardant Health, Inc.
|
2,786 | $417,983 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,581 | $358,554 |
All Filings in LH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,791,160 | 6,397 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,057,642 | 11,460 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||